Arkolith/Insider Trading/KYNB/Form 4/A

Wettig Thane

CEO, DirectorKYNTRA BIO, INC. (KYNB) · full profile →Form 4/A · filed May 19, 2026
Net Buying
Open-Market Buys
$20K
Open-Market Sells
$0
Net Open-Market Flow
$20K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2026Buy(P)3K$7.09$20K27K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001815638-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML